Copyright
©The Author(s) 2017.
World J Cardiol. Apr 26, 2017; 9(4): 320-331
Published online Apr 26, 2017. doi: 10.4330/wjc.v9.i4.320
Published online Apr 26, 2017. doi: 10.4330/wjc.v9.i4.320
Table 1 The disease enrichment analysis
Disease | Gene No. | Adjusted value |
Cardiovascular diseases | 59 | 4.38E-05 |
Heart diseases | 50 | 0.0002 |
Vascular diseases | 49 | 0.0003 |
Cardiovascular abnormalities | 27 | 0.0003 |
Bradycardia | 9 | 0.0067 |
congenital long QT syndrome | 6 | 0.0094 |
Metaplasia | 26 | 0.0094 |
Cerebrovascular disorders | 25 | 0.0094 |
Arrhythmias, cardiac | 19 | 0.0094 |
Syncope | 12 | 0.0094 |
Romano-ward syndrome | 6 | 0.0094 |
Neovascularization, pathologic | 24 | 0.0094 |
Atrial fibrillation | 14 | 0.0094 |
Glycogen storage disease | 8 | 0.0097 |
Myocardial ischemia | 34 | 0.0097 |
Glycogen storage disease, type IV | 5 | 0.0181 |
Heart murmurs | 4 | 0.0207 |
Congenital abnormalities | 61 | 0.0207 |
Adhesion | 64 | 0.0207 |
Heart defects, congenital | 17 | 0.0207 |
Ventricular dysfunction | 14 | 0.0207 |
Atrioventricular block nitrous oxide system | 8 | 0.0264 |
Heart block | 11 | 0.0315 |
Parkinson disease | 18 | 0.0450 |
Mesothelioma | 10 | 0.0450 |
Coronary artery disease | 31 | 0.0450 |
Stress | 50 | 0.0450 |
Coronary disease | 31 | 0.0450 |
Jervell-lange nielsen syndrome | 4 | 0.0450 |
Table 2 The significantly enriched gene pathways
Pathway name | No. Gene | Adjusted value |
Insulin signaling pathway | 28 | 9.47E-06 |
Endocytosis | 33 | 0.0003 |
Hypertrophic cardiomyopathy | 15 | 0.0171 |
Arrhythmogenic right ventricular cardiomyopathy | 13 | 0.0385 |
Extracellular matrix-receptor interaction | 14 | 0.0445 |
Focal adhesion | 24 | 0.0462 |
Prostate cancer | 14 | 0.0462 |
Tryptophan metabolism | 9 | 0.0462 |
Pathways in cancer | 35 | 0.0462 |
MAPK signaling pathway | 30 | 0.0462 |
Table 3 Differentially expressed proteins identified by MALDI MS-MS
No. | Protein code | Gene ID | KI/WT | KO/WT | KO/KI | Pathways |
1 | PKP1 | 18772 | 1.76 | -1.13 | -1.99 | Focal adhesion, apoptosis |
2 | HRC | 15464 | 1.62 | 1.06 | -1.53 | Calcium signaling |
4 | PYGB | 53313 | 1.61 | 1.16 | -1.39 | Glucagon signaling, insulin signaling |
5 | MSN1 | 17698 | -2.68 | 4.71 | 12.57 | Cell shape, actin-cytoskeleton |
6 | VINC | 22330 | -4.18 | 4.96 | 20.64 | Cell-cell adhesion, cell shape, actin cytoskeleton |
8 | SYNE11 | 64009 | -3.59 | 5.82 | 20.82 | Nucleus-cytoskeleton connection |
14 | ADAM10 | 11487 | 1.71 | -1.18 | -2.02 | Inflammation, amiloidosis |
17 | TNPO3 | 320938 | -1.11 | 1.51 | 1.67 | Nucleus-cytoskeleton connection |
18 | CAPN8 | 170725 | 2.15 | -1.02 | -2.19 | Inflammation |
19 | CGNL1 | 68178 | 1.58 | -1.03 | -1.63 | Focal adhesion |
20 | VIM | 22352 | 1.43 | 1.40 | -1.02 | Cell division, fibrosis |
23 | MYH6 | 17888 | 1.02 | -3.41 | -3.49 | Sarcomere, actin-cytoskeleton |
24 | NRAP | 18175 | -1.03 | 1.79 | 1.84 | Focal adhesion, actin cytoskeleton |
28 | ANXA3 | 20480 | 1.23 | -1.80 | -2.23 | Prostaglandin synthesis and regulation |
29 | LATS2 | 23805 | -1.58 | -1.51 | 1.04 | Hippo signaling pathway, DNA damage |
32 | SPTB1 | 20741 | 1.56 | -1.01 | -1.59 | Actin-cytoskeleton |
33 | GCC2 | 11426 | 1.04 | -3.78 | -3.92 | Vesicle-mediated transport, retrograde transport at the trans-Golgi-network |
37 | ACADS | 12306 | -2.01 | 1.12 | 2.24 | Mitochondrial fatty acid beta-oxidation |
39 | FHL2 | 14200 | 1.05 | -2.25 | -2.37 | Focal adhesion, Wnt, calcineurin signaling |
39 | MYOZ2 | 59006 | 1.05 | -2.25 | -2.37 | Cytoskeleton, calcineurin signaling, myofibrillogenesis |
47 | FGF9 | 14180 | 2.93 | 5.90 | 2.01 | Fibrosis |
53 | DST | 13518 | 2.23 | 1.01 | -2.21 | Focal adhesion, actin cytoskeleton |
59 | FEZ2 | 56069 | 1.89 | -1.11 | -2.12 | N/A |
59 | CSRP3 | 13009 | 1.89 | -1.11 | -2.12 | Stress sensing, myogenesis |
62 | MYOM1 | 319565 | -1.37 | 1.58 | 2.15 | Striated muscle contraction |
63 | MYOM2 | 17930 | +++ | Sarcomere | ||
65 | EZR/MSN | 17698 | +++ | Cell surface organization, adhesion, microtubule |
Table 4 Genes whose gene expression has significant correlation with Mypn and gene product have significant change comparing with KI or KO mice
Protein code | Corr P value | KI/WT | KO/WT | KO/KI |
CGNL1 | 0.0024 | 1.58 | -1.03 | -1.63 |
PKP1 | 0.0082 | 1.76 | -1.13 | -1.99 |
SYNE11 | 0.0114 | -3.59 | 5.82 | 20.82 |
PYGB | 0.0157 | 1.61 | 1.16 | -1.39 |
MSN | 0.0194 | -2.68 | 4.71 | 12.57 |
ANXA3 | 0.0319 | 1.23 | -1.8 | -2.23 |
MYOM11 | 0.0335 | -1.37 | 1.58 | 2.15 |
ACADS | 0.035 | -2.01 | 1.12 | 2.24 |
GCC2 | 0.0375 | 1.04 | -3.78 | -3.92 |
FEZ2 | 0.0399 | 1.89 | -1.11 | -2.12 |
LATS2 | 0.0431 | -1.58 | -1.51 | 1.04 |
- Citation: Gu Q, Mendsaikhan U, Khuchua Z, Jones BC, Lu L, Towbin JA, Xu B, Purevjav E. Dissection of Z-disc myopalladin gene network involved in the development of restrictive cardiomyopathy using system genetics approach. World J Cardiol 2017; 9(4): 320-331
- URL: https://www.wjgnet.com/1949-8462/full/v9/i4/320.htm
- DOI: https://dx.doi.org/10.4330/wjc.v9.i4.320